Division of Antibody Project, Institute for Comprehensive Medical Science, Fujita Health University, Dengakugakubo 1-98, Kutsukake, Toyoake, Aichi 470-1192, Japan.
Immunol Lett. 2011 Apr 30;136(1):44-8. doi: 10.1016/j.imlet.2010.12.001. Epub 2010 Dec 13.
The use of phage-displayed antibody libraries has enabled the isolation of several thousand cancer-specific monoclonal antibodies. To further select for clones among these antibodies which have therapeutic potential for cancer, several types of in vitro anti-tumor assay, such as an antibody-dependent cell-mediated cytotoxicity (ADCC) assay, are required. The cytotoxic activities of effector cells are triggered by the binding of the Fc portion of IgG to its receptor, necessitating the conversion of a candidate clone with a single-chain variable fragment (scFv) form into a human IgG form. In the laboratory however, this conversion process is expensive and involves laborious steps such as the cloning of mammalian cells that contain an IgG expression vector, the subsequent production of protein, and affinity purification. In our current study, we show that an original fusion of scFv and protein III, a coat protein of the M13 bacteriophage, can induce ADCC activity towards its target cells in the presence of a rabbit anti-protein III polyclonal antibody. Our modified assay method thus enables the more rapid selection of potentially therapeutic clones from phage-displayed antibody libraries.
噬菌体展示抗体库的应用使得能够分离出数千种针对癌症的单克隆抗体。为了进一步从这些抗体中选择具有治疗癌症潜力的克隆,需要几种类型的体外抗肿瘤测定,例如抗体依赖性细胞介导的细胞毒性 (ADCC) 测定。效应细胞的细胞毒性活性是通过 IgG 的 Fc 部分与受体结合触发的,这需要将具有单链可变片段 (scFv) 形式的候选克隆转化为人 IgG 形式。然而,在实验室中,这个转化过程非常昂贵,并且涉及到繁琐的步骤,例如克隆含有 IgG 表达载体的哺乳动物细胞,随后生产蛋白质,并进行亲和纯化。在我们目前的研究中,我们表明,scFv 和 M13 噬菌体的外壳蛋白蛋白 III 的原始融合可以在兔抗蛋白 III 多克隆抗体的存在下诱导针对其靶细胞的 ADCC 活性。因此,我们修改的测定方法能够更快速地从噬菌体展示抗体库中选择潜在的治疗性克隆。